Results for the year ended 30 June 2025

Summary by AI BETAClose X

For the year ended June 30, 2025, Bioventix PLC reported a revenue decrease of 4% to £13.1 million, down from £13.6 million in 2024. The profit before tax also decreased by 5% to £10.1 million, compared to £10.6 million the previous year. The company's cash balance at year-end was £5.1 million, a decrease from £6.0 million in 2024. Despite these declines, sales of vitD3.5H10 increased by 12% to £6.6 million. Sales to Chinese IVD companies totaled £2.4 million, representing 18% of total revenues, a reduction of approximately 7% compared to the previous year. A second interim dividend of 80p per share was declared, bringing the total dividend for the year to 150p per share, a decrease from 155p per share in 2024.

Disclaimer*

Companies

Bioventix (BVXP)
UK 100

Latest directors dealings